Conversely, in the ESR1 Y537S mutant PDX model, palbociclib alone or in combination with bazedoxifene similarly inhibited tumor growth, but the combination proved more effective in decreasing Ki67 expression than either agent given as monotherapy [37]. Here, ESR1 is linked to neoplasm.